The world's first non-COVID-19 mRNA vaccine has been approved! The market is a blue ocean. Can the RSV newcomer make a comeback?

① A "newcomer" has entered the multi-billion dollar RSV vaccine market, and it is also the world's first non-COVID mRNA vaccine approved. ② Analysis shows that whether it is recombinant protein vaccine or mRNA vaccine, which technology route can better meet clinical needs in the future will be the key evaluation. ③ The advantage of the mRNA vaccine lies in its low cost and fast R&D and production.

cls.cn18:34

Dow, S&P, and Nasdaq Finished Higher After a Choppy Trading Session

Seeking Alpha15:02

Viking Falls Despite Positive Mid-stage Data for Liver Drug

Seeking Alpha14:40

Eli Lilly Wins Favorable Terms for Obesity Drug Use in U.K.

Seeking Alpha13:57

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

On Friday, Pfizer Inc (NYSE:PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ:MRNA) and Merck & Co (NYSE:

Benzinga12:45

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

Benzinga12:35